Pages that link to "Q56565980"
Jump to navigation
Jump to search
The following pages link to MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner (Q56565980):
Displaying 50 items.
- Li-fraumeni syndrome (Q22241780) (← links)
- Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck (Q24630090) (← links)
- An integrative view on sex differences in brain tumors (Q26829861) (← links)
- The genetics of the p53 pathway, apoptosis and cancer therapy (Q27863460) (← links)
- Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore (Q28386766) (← links)
- Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer (Q28482457) (← links)
- Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis (Q28576835) (← links)
- Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer (Q28816916) (← links)
- Therapeutic considerations for Mdm2: not just a one trick pony (Q30380490) (← links)
- An information-theoretic analysis of genetics, gender and age in cancer patients (Q33327370) (← links)
- Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene (Q33330479) (← links)
- MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians (Q33330490) (← links)
- MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism. (Q33373153) (← links)
- Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations (Q33410398) (← links)
- Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore (Q33539409) (← links)
- Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults (Q33569279) (← links)
- Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations (Q33593066) (← links)
- Germline mutations and polymorphisms in the origins of cancers in women (Q33606675) (← links)
- MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis (Q33643505) (← links)
- Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice (Q33703779) (← links)
- A functionally significant SNP in TP53 and breast cancer risk in African-American women (Q33731355) (← links)
- Single-nucleotide polymorphisms in the p53 signaling pathway. (Q33800384) (← links)
- Map making in the 21st century: charting breast cancer susceptibility pathways in rodent models (Q33908246) (← links)
- Single-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer risk (Q33932445) (← links)
- The ups and downs of p53: understanding protein dynamics in single cells (Q33941653) (← links)
- The p53 orchestra: Mdm2 and Mdmx set the tone (Q34020353) (← links)
- MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group (Q34043467) (← links)
- A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development (Q34148472) (← links)
- Genetic variation in cell death genes and risk of non-Hodgkin lymphoma (Q34162892) (← links)
- MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk (Q34257381) (← links)
- Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population. (Q34268286) (← links)
- Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome (Q34324382) (← links)
- Decreased Mdm2 expression inhibits tumor development and extends survival independent of Arf and dependent on p53. (Q34430887) (← links)
- Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers (Q34435034) (← links)
- The MDM2 gene family (Q34460686) (← links)
- Radiation-induced apoptosis varies among individuals and is modified by sex and age. (Q34463885) (← links)
- A 40-bp insertion/deletion polymorphism of Murine Double Minute2 (MDM2) increased the risk of breast cancer in Zahedan, Southeast Iran. (Q34475865) (← links)
- Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649). (Q34483516) (← links)
- The dynamic control of signal transduction networks in cancer cells (Q34490200) (← links)
- Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death (Q34496093) (← links)
- Molecular mechanism of mutant p53 stabilization: the role of HSP70 and MDM2. (Q34516626) (← links)
- The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls (Q34575963) (← links)
- A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients (Q34626391) (← links)
- Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies (Q34653644) (← links)
- Natural selection and functional genetic variation in the p53 pathway (Q34718094) (← links)
- Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity (Q34786668) (← links)
- Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes (Q34904277) (← links)
- Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma (Q34968358) (← links)
- An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk (Q35010195) (← links)
- A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation (Q35029505) (← links)